Table 6.
Outcomes of patients in the clopidogrel and ticagrelor groups.
| Clopidogrel (n = 223) | Ticagrelor (n = 214) | P value | |
|---|---|---|---|
| Major adverse cardiac events | 17 (7.6%) | 6 (2.8%) | 0.031 |
| Acute coronary syndrome, n (%) | 14 (6.2%) | 6 (2.8%) | |
| Heart failure, n (%) | 1 (0.4%) | 0 | |
| Cerebrovascular events, n (%) | 1 (0.4%) | 0 | |
| Cardiac death, n (%) | 1 (0.4%) | 0 | |
| Noncardiac death, n (%) | 3 (1.3%) | 1 (0.4%) | 0.371 |
| Bleeding, n (%) | 7 (3.2%) | 8 (3.8%) | 0.799 |